FDA 483 - Shine & Pretty USA Corporation - March 04, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Outline & Pretty USA Corporation in Camarillo, CA, a drug manufacturer, was inspected by the FDA and cited for significant deficiencies in quality control. Observations included a lack of written procedures for production, process controls, and change control, as well as failures to investigate unexplained discrepancies in material testing. The firm also maintained an unsuitable facility with cracked floors and unsealed openings, and had deficient instrument calibration procedures.
ID · dbf807df-3eff-42c6-adb0-3d7e7fe4d886